This joint guideline of ANZCA, ACEM, RACP and ACCRM will assist medical practitioners in ‘diagnosing’ dying, considering the intention of the proposed intervention, promoting shared-care decision and cultural safety, and mitigating the potential for clinical momentum.
ACEM’s philosophy that clinical, epidemiological and laboratory research are essential 24-hour core ED activities. CTNs, Clinical Quality Registries, the MRFF extension and re-emphasis of targeted translation topics and for networks to bring together clinical researchers and epidemiologists to develop and support best practice.
ACEM supportive of transferring patients out of EDs into specialist care as soon as clinically appropriate. ACEM identifies resourcing as a potential issue within the Plan and noted that in the Action Plan’s cost analysis, the opportunity cost of not treating other patients due to resourcing stroke clot retrieval has not been determined.
The NZ National Sepsis Action Plan outlines an equitable, inclusive, evidence based and dynamic approach to sepsis prevention, recognition and treatment. The strong governance model and building on system strengths to overcome the barriers will ensure success.
ACEM provided a short submission in response to the Western Australian Department of Health stakeholder review of the draft monitored medicine prescribing code (the draft code). ACEM is broadly supportive of the draft code.
The ACEM submission to the Australian Commission on Safety and Quality in Health Care on their draft Standard on opioid analgesic stewardship in acute pain clinical care.
ACEM participated in the Queensland Department of Health review of the Patient Access to Care Health Service Directive and associated protocols.
ACEM confirmed support for the Choosing Wisely Pharmacy Recommendations with comments around in-pharmacy opportunistic diagnostic testing, the process around dispensing of regular opioids and additional guidance and training for pharmacists or other healthcare professionals regarding the use of complementary and alternative medicines.
On current evidence, intravenous thrombolysis as an intervention for acute stroke, administered to selected patients within three hours of symptom onset, may increase the odds of a better functional outcome. This is despite thrombolysis in stroke increasing the risk of intracranial haemorrhage and conferring no mortality benefit.
The Quality Standards and its associated Toolkit have been developed to assist clinicians with implementing the Quality Standards in their own emergency departments (EDs) and other services providing emergency care.